French pharma SaaS startup Biolevate raised a €30M Series A co-led by RAISE France and Orange Ventures, taking its total funding to €36M (Brock E.W. Turner/Axios)

Brock E.W. Turner / Axios: French pharma SaaS startup Biolevate raised a €30M Series A co-led by RAISE France and Orange Ventures, taking its total funding to €36M  —  Biolevate, a French pharma-focused SaaS startup, raised €30 million in Series A funding, CEO Joël Belafa tells Axios Pro exclusively.